Free Trial

Thermo Fisher Scientific (TMO) Stock Price, News & Analysis

Thermo Fisher Scientific logo
$674.18 +11.14 (+1.68%)
Closing price 03:59 PM Eastern
Extended Trading
$679.10 +4.92 (+0.73%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Thermo Fisher Scientific Stock (NYSE:TMO)

Advanced

Key Stats

Today's Range
$659.00
▼
$681.50
50-Day Range
$579.85
▼
$681.04
52-Week Range
$435.27
▼
$694.33
Volume
2.49 million shs
Average Volume
2.36 million shs
Market Capitalization
$249.28 billion
P/E Ratio
27.82
Dividend Yield
0.28%
Price Target
$642.33
Consensus Rating
Moderate Buy

Company Overview

Thermo Fisher Scientific Inc. is a global provider of laboratory products, analytical instruments, reagents, consumables, software and services. Its offerings support research, drug discovery and development, clinical diagnostics, biotechnology and pharmaceutical manufacturing, as well as environmental, industrial and other applied markets.

The company’s portfolio includes mass spectrometers, genetic analysis and sequencing systems, electron microscopes, chromatography equipment, laboratory plastics, cell culture products, antibodies, protein and molecular biology reagents, and diagnostic testing solutions. Thermo Fisher also provides contract development and manufacturing services, clinical research services, laboratory management, instrument maintenance and other support through brands that include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services.

Thermo Fisher was created in 2006 through the merger of Thermo Electron and Fisher Scientific. Headquartered in Waltham, Massachusetts, the company serves customers worldwide through a broad international manufacturing, distribution and service network. Marc N. Casper has served as the company’s president and chief executive officer since 2009 and has also held leadership roles on its board.

AI Generated. May Contain Errors.

Thermo Fisher Scientific Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
81st Percentile Overall Score

TMO MarketRank™: 
4.06027902079 of 5 stars

Thermo Fisher Scientific scored higher than 81% of companies evaluated by MarketBeat, and ranked 92nd out of 873 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Thermo Fisher Scientific has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 2 strong buy ratings, 18 buy ratings, 3 hold ratings, and 2 sell ratings.

  • Upside/Downside

    The consensus price target for Thermo Fisher Scientific is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Thermo Fisher Scientific has been the subject of 15 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Thermo Fisher Scientific's stock forecast and price target.
  • Earnings Growth

    Earnings for Thermo Fisher Scientific are expected to grow by 9.51% in the coming year, from $25.13 to $27.52 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Thermo Fisher Scientific is 27.82, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 40.69.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Thermo Fisher Scientific is 27.82, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 193.91.

  • Price to Earnings Growth Ratio

    Thermo Fisher Scientific has a PEG Ratio of 2.77. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Thermo Fisher Scientific has a P/B Ratio of 4.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Thermo Fisher Scientific's valuation and earnings.
  • Percentage of Shares Shorted

    1.47% of the float of Thermo Fisher Scientific has been sold short.
  • Short Interest Ratio / Days to Cover

    Thermo Fisher Scientific has a short interest ratio ("days to cover") of 2.07, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Thermo Fisher Scientific has recently increased by 7.73%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Thermo Fisher Scientific has a dividend yield of 0.28%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Thermo Fisher Scientific has been increasing its dividend for 8 years.

  • Dividend Coverage

    The dividend payout ratio of Thermo Fisher Scientific is 10.11%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Thermo Fisher Scientific will have a dividend payout ratio of 6.83% next year. This indicates that Thermo Fisher Scientific will be able to sustain or increase its dividend.

  • Read more about Thermo Fisher Scientific's dividend.
  • News Sentiment

    Thermo Fisher Scientific has a news sentiment score of 1.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 38 news articles for Thermo Fisher Scientific this week, compared to 8 articles on an average week.
  • Search Interest

    35 people have searched for TMO on MarketBeat in the last 30 days. This is an increase of 46% compared to the previous 30 days.
  • MarketBeat Follows

    13 people have added Thermo Fisher Scientific to their MarketBeat watchlist in the last 30 days. This is an increase of 44% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Thermo Fisher Scientific insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $44,122,820.00 in company stock.

  • Percentage Held by Insiders

    0.33% of the stock of Thermo Fisher Scientific is held by insiders.

  • Percentage Held by Institutions

    89.23% of the stock of Thermo Fisher Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Thermo Fisher Scientific's insider trading history.
Receive TMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Thermo Fisher Scientific and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TMO Stock News Headlines

AI Is Speeding Up Drug Discovery, but FDA Trial Phases Still Decide Which Biotech Stocks Win
Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built (TMO)
Biotech stocks trade on FDA trial phases. Phase 2 data often builds value, cash runway limits dilution, and Quantum BioPharma just began a phase 2 MS trial.
Did you grab your copy yet?
Bill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarter he swaps in a brand-new list, and once the new edition launches, this one disappears. Investors who want a current snapshot of his picks should grab a copy now and save it before the switch happens.tc pixel
Thermo Fisher Scientific (TMO) Set to Release Earnings on Wednesday
See More Headlines

TMO Stock Analysis - Frequently Asked Questions

Thermo Fisher Scientific's stock was trading at $579.42 on January 1st, 2026. Since then, TMO shares have increased by 16.4% and is now trading at $674.1840.

Thermo Fisher Scientific Inc. (NYSE:TMO) issued its quarterly earnings data on Thursday, July, 23rd. The medical research company reported $6.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.71 by $0.32. The company's quarterly revenue was up 10.5% compared to the same quarter last year.
Read the conference call transcript
.

Thermo Fisher Scientific's board approved a stock buyback program on Thursday, November 6th 2025, which allows the company to buy back $5,000,000,000 in shares, according to EventVestor. This means that the company could buy up to 2.4% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company's management believes its stock is undervalued.

Thermo Fisher Scientific subsidiaries include Henogen, Phinotex, Qiagen, Brammer Bio, HighChem, Gatan Inc, IntegenX, and more.

Top institutional shareholders of Thermo Fisher Scientific include Douglas Lane & Associates LLC (0.06%), Perpetual Ltd (0.04%), Mn Services Vermogensbeheer B.V. (0.03%) and Quintet Private Bank Europe S.A. (0.02%). Insiders that own company stock include Marc N Casper, Michel Lagarde, Stephen Williamson, Gianluca Pettiti, Michael D Shafer, Lisa P Britt, Frederick M Lowery, Michael A Boxer, Joseph R Holmes and Debora L Spar.
View institutional ownership trends
.

Shares of TMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Thermo Fisher Scientific investors own include NVIDIA (NVDA), Visa (V), Salesforce (CRM), Advanced Micro Devices (AMD), Tesla (TSLA), Mastercard (MA) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
7/23/2026
Record date for 10/15 Dividend
9/15/2026
Ex-Dividend for 10/15 Dividend
9/15/2026
Today
10/14/2026
Dividend Payable
10/15/2026
Next Earnings (Estimated)
10/21/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NYSE:TMO
CIK
97745
Employees
125,000
Year Founded
1956

Price Target and Rating

High Price Target
$760.00
Low Price Target
$520.00
Potential Upside/Downside
-4.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
25 Analysts

Profitability

EPS (Trailing Twelve Months)
$18.59
Trailing P/E Ratio
27.82
Forward P/E Ratio
26.83
P/E Growth
2.77
Net Income
$6.70 billion
Net Margins
15.04%
Pretax Margin
16.48%
Return on Equity
17.09%
Return on Assets
8.12%

Debt

Debt-to-Equity Ratio
0.74
Current Ratio
1.55
Quick Ratio
1.18

Sales & Book Value

Annual Sales
$44.56 billion
Price / Sales
5.59
Cash Flow
$30.91 per share
Price / Cash Flow
21.81
Book Value
$142.17 per share
Price / Book
4.74

Miscellaneous

Outstanding Shares
369,750,000
Free Float
368,527,000
Market Cap
$249.28 billion
Optionable
Optionable
Beta
0.87

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NYSE:TMO) was last updated on 10/14/2026 by MarketBeat.com Staff.
From Our Partners